Oocyte Cryopreservation for Fertility Preservation in Postpubertal Female Children at Risk for Premature Ovarian Failure Due to Accelerated Follicle Loss in Turner Syndrome or Cancer Treatments

Overview

Journal J Pediatr Adolesc Gynecol

Specialties Gynecology & Obstetrics
Pediatrics

Date 2014 Sep 13

PMID 25214440

Citations 30

Authors

K Oktay

G Bedoschi

Affiliations

Soon will be listed here.

Abstract

Objective: To preliminarily study the feasibility of oocyte cryopreservation in postpubertal girls aged between 13 and 15 years who were at risk for premature ovarian failure due to the accelerated follicle loss associated with Turner syndrome or cancer treatments.

Design: Retrospective cohort and review of literature.

Setting: Academic fertility preservation unit.

Participants: Three girls diagnosed with Turner syndrome, 1 girl diagnosed with germ-cell tumor. and 1 girl diagnosed with lymphoblastic leukemia.

Interventions: Assessment of ovarian reserve, ovarian stimulation, oocyte retrieval, in vitro maturation, and mature oocyte cryopreservation.

Main Outcome Measure: Response to ovarian stimulation, number of mature oocytes cryopreserved and complications, if any.

Results: Mean anti-müllerian hormone, baseline follical stimulating hormone, estradiol, and antral follicle counts were 1.30 ± 0.39, 6.08 ± 2.63, 41.39 ± 24.68, 8.0 ± 3.2; respectively. In Turner girls the ovarian reserve assessment indicated already diminished ovarian reserve. Ovarian stimulation and oocyte cryopreservation was successfully performed in all female children referred for fertility preservation. A range of 4-11 mature oocytes (mean 8.1 ± 3.4) was cryopreserved without any complications. All girls tolerated the procedure well.

Conclusions: Oocyte cryopreservation is a feasible technique in selected female children at risk for premature ovarian failure. Further studies would be beneficial to test the success of oocyte cryopreservation in young girls.

Citing Articles

Clinical and ethical perspectives of ovarian stimulation and oocyte cryopreservation in adolescents: 6 years experience from a tertiary centre.

Latif S, Davies M, Vaughan E, Mavrelos D, Lavery S, Yasmin E Hum Reprod Open. 2025; 2025(1):hoaf005.

PMID: 39959763 PMC: 11825388. DOI: 10.1093/hropen/hoaf005.

Female fertility preservation for family planning: a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR).

Massarotti C, Cimadomo D, Spadoni V, Conforti A, Zaca C, Carosso A J Assist Reprod Genet. 2024; 41(9):2521-2535.

PMID: 39030346 PMC: 11405660. DOI: 10.1007/s10815-024-03197-4.

Clinical practice guidelines for the care of girls and women with Turner syndrome.

Gravholt C, Andersen N, Christin-Maitre S, Davis S, Duijnhouwer A, Gawlik A Eur J Endocrinol. 2024; 190(6):G53-G151.

PMID: 38748847 PMC: 11759048. DOI: 10.1093/ejendo/lvae050.

Navigating fertility dilemmas across the lifespan in girls with Turner syndrome-a scoping review.

van der Coelen S, van der Velden J, Nadesapillai S, Braat D, Peek R, Fleischer K Hum Reprod Update. 2024; 30(4):383-409.

PMID: 38452347 PMC: 11215162. DOI: 10.1093/humupd/dmae005.

Controlled ovarian stimulation in cancer patients under 18 years old; a case series.

Yahyaei A, Moridi M, Ghaffari F J Ovarian Res. 2024; 17(1):33.

PMID: 38317250 PMC: 10840237. DOI: 10.1186/s13048-024-01352-0.

References

Huang J, Tulandi T, Holzer H, Tan S, Chian R . Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril. 2007; 89(3):567-72. DOI: 10.1016/j.fertnstert.2007.03.090. View

Hadnott T, Gould H, Gharib A, Bondy C . Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertil Steril. 2011; 95(7):2251-6. PMC: 3130000. DOI: 10.1016/j.fertnstert.2011.03.085. View

Lie Fong S, Visser J, Welt C, de Rijke Y, Eijkemans M, Broekmans F . Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012; 97(12):4650-5. PMC: 3683801. DOI: 10.1210/jc.2012-1440. View

Herrero L, Martinez M, Garcia-Velasco J . Current status of human oocyte and embryo cryopreservation. Curr Opin Obstet Gynecol. 2011; 23(4):245-50. DOI: 10.1097/GCO.0b013e32834874e2. View

Oktem O, Oktay K . Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer. 2007; 110(10):2222-9. DOI: 10.1002/cncr.23071. View

Bedaiwy M, Shahin A, Falcone T . Reproductive organ transplantation: advances and controversies. Fertil Steril. 2008; 90(6):2031-55. DOI: 10.1016/j.fertnstert.2008.08.009. View

Oktay K, Newton H, Aubard Y, Salha O, Gosden R . Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology?. Fertil Steril. 1998; 69(1):1-7. DOI: 10.1016/s0015-0282(97)00207-0. View

Nishio S, Ushijima K, Fukui A, Fujiyoshi N, Kawano K, Komai K . Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary. J Obstet Gynaecol Res. 2006; 32(4):416-21. DOI: 10.1111/j.1447-0756.2006.00417.x. View

Sonmezer M, Oktay K . Fertility preservation in female patients. Hum Reprod Update. 2004; 10(3):251-66. DOI: 10.1093/humupd/dmh021. View

10.

Loren A, Mangu P, Beck L, Brennan L, Magdalinski A, Partridge A . Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31(19):2500-10. PMC: 5321083. DOI: 10.1200/JCO.2013.49.2678. View

11.

Borgstrom B, Birgit B, Hreinsson J, Julius H, Rasmussen C, Carsten R . Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles. J Clin Endocrinol Metab. 2008; 94(1):74-80. DOI: 10.1210/jc.2008-0708. View

12.

. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2012; 99(1):37-43. DOI: 10.1016/j.fertnstert.2012.09.028. View

13.

Karnis M . Fertility, pregnancy, and medical management of Turner syndrome in the reproductive years. Fertil Steril. 2012; 98(4):787-91. DOI: 10.1016/j.fertnstert.2012.08.022. View

14.

Jadoul P, Dolmans M, Donnez J . Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed?. Hum Reprod Update. 2010; 16(6):617-30. DOI: 10.1093/humupd/dmq010. View

15.

Lau N, Huang J, MacDonald S, Elizur S, Gidoni Y, Holzer H . Feasibility of fertility preservation in young females with Turner syndrome. Reprod Biomed Online. 2009; 18(2):290-5. DOI: 10.1016/s1472-6483(10)60268-4. View

16.

Reichman D, Davis O, Zaninovic N, Rosenwaks Z, Goldschlag D . Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome. Fertil Steril. 2012; 98(5):1225-8. DOI: 10.1016/j.fertnstert.2012.07.1056. View

17.

Newton H, Aubard Y, Rutherford A, Sharma V, Gosden R . Low temperature storage and grafting of human ovarian tissue. Hum Reprod. 1996; 11(7):1487-91. DOI: 10.1093/oxfordjournals.humrep.a019423. View

18.

Parkinson C, Hatcher H, Ajithkumar T . Management of malignant ovarian germ cell tumors. Obstet Gynecol Surv. 2011; 66(8):507-14. DOI: 10.1097/OGX.0b013e318234ede9. View

19.

Rossi B, Missmer S, Correia K, Wadleigh M, Ginsburg E . Ovarian reserve in women treated for acute lymphocytic leukemia or acute myeloid leukemia with chemotherapy, but not stem cell transplantation. ISRN Oncol. 2012; 2012:956190. PMC: 3461295. DOI: 10.5402/2012/956190. View

20.

Hovatta O . Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatr Endocrinol Rev. 2012; 9 Suppl 2:713-7. View